Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Sandip Patel, MD, on treatment in the 2nd line setting following PD-L1 targeting agents

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC San Diego Moores Cancer Center, explains how to treat 2nd line patients who have received Keytruda or other PD-L1 targeting agents as a part of 1st line therapy

Tags: ASCO Conference CoverageLung (includes NSCLC, SCLC, Mesothelioma)

Published: 12 June 2019

Recent Videos

video

Lalan Wilfong, MD, on removing drugs from clinical pathways & the impact on value-based care

Dr. Wilfong, Executive Vice President, Value Based Care Programs, Texas Oncology, discusses whether removing a drug from clinical pathways can ...

video

Deborah Korenstein, MD, speculates on the best solution to prevent the overuse of health services

Dr. Korenstein, Memorial Sloan Kettering Cancer Center, speculates on the best solution to prevent the overuse of health services in ...

video

Lalan Wilfong, MD, considers compliance issues after removing a drug from clinical pathways

Dr. Wilfong, Executive Vice President, Value Based Care Programs, Texas Oncology, considers compliance issues after removing a drug from clinical ...

video

Robin Zon, MD, FACP, FASCO, considers what practices should know about value-based contracting

Dr. Zon, Medical Oncologist and President, Michiana Hematology Oncology, offers her opinion on what practices should know about value-based contracting

video

Deborah Korenstein, MD, on the benefits & harm of overuse of health services in cancer care

Dr. Korenstein, Memorial Sloan Kettering Cancer Center, discusses the benefits and harm of overuse of health services in the management ...

video

Nathan Handley, MD, on how collaborating with payers can help eliminate prior authorization

Dr. Handley, Medical Oncologist, Thomas Jefferson University, explains how collaborating with payers can help eliminate the need for prior authorization

video

Lalan Wilfong, MD, analyzes successful models that incorporate care into multisite networks

Dr. Wilfong, Executive Vice President, Value Based Care Programs, Texas Oncology, considers what makes a successful model in terms of ...

video

Kerin Adelson, MD, considers what value-based payment programs have focused on to reduce costs

Dr. Adelson, Associate Professor, Chief Quality Officer and Deputy Chief Medical Officer, Smilow Cancer Hospital, Yale Cancer Center, elaborates on ...

video

Nina Bickell, MD, MPH, elaborates on outcomes from the SWOG trials

Dr. Bickell, Professor, Department of Population Health Science & Policy, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, ...

video

Robin Zon, MD, FACP, FASCO, on leveraging data to provide quality cancer care

Dr. Zon, Medical Oncologist and President, Michiana Hematology Oncology, provides examples of how Michiana Hematology Oncology is leveraging data to ...

Related Videos

video-image

Robin Zon, MD, FACP, FASCO, on leveraging data in a value-based world

video-image

Nina Bickell, MD, MPH, regarding physician attitudes toward cancer clinical trial enrollment

video-image

Robin Zon, MD, FACP, FASCO, on leveraging data to provide quality cancer care

video-image

Robin Zon, MD, FACP, FASCO, considers what practices should know about value-based contracting

video-image

Nina Bickell, MD, MPH, elaborates on outcomes from the SWOG trials

video-image

Lalan Wilfong, MD, considers compliance issues after removing a drug from clinical pathways

video-image

Lalan Wilfong, MD, on the challenges associated with quality care & multisite networks

video-image

Kerin Adelson, MD, considers what value-based payment programs have focused on to reduce costs

video-image

Deborah Korenstein, MD, speculates on the best solution to prevent the overuse of health services

video-image

Nathan Handley, MD, explains why payers may refuse to fund effective cancer therapies

video-image

Lalan Wilfong, MD, analyzes successful models that incorporate care into multisite networks

video-image

Deborah Korenstein, MD, shares examples of how health services have been overused in cancer care

video-image

Nathan Handley, MD, on how collaborating with payers can help eliminate prior authorization

video-image

Deborah Korenstein, MD, on the benefits & harm of overuse of health services in cancer care

video-image

Lalan Wilfong, MD, on removing drugs from clinical pathways & the impact on value-based care

video-image

Paul Forsberg, PharmD, BCOP, MHA, offers thoughts regarding the delivery of quality care

video-image

Paul Forsberg, PharmD, BCOP, MHA, on successes & obstacles with medically integrated pharmacies

video-image

Stephen Grubbs, MD, FASCO, shares a message to practices considering value-based contracting

video-image

Ira Zackon, MD, explains how medically integrated pharmacies collaborate to provide quality care

video-image

Linda Bosserman, MD, FACP, FASCO, regarding major topics from the 2019 Oncology Practice Conference